Pramipexol Extended Release

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Early Parkinson Disease (Early PD)Parkinson Disease

Phase 3

Pivotal Study in Advanced Parkinsons Disease Patients

CompletedNCT00466167

Boehringer IngelheimParkinson Disease

Start: 2007-04-30Updated: 2014-07-08

Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients

CompletedNCT00479401

Boehringer IngelheimEarly Parkinson Disease (Early PD)

Start: 2007-05-31Updated: 2014-07-17

Related Papers

Comparison of nocturnal symptoms in advanced Parkinson's disease patients with sleep disturbances: pramipexole sustained release versus immediate release formulations.

2018-07-0422 citations